SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (397)9/7/1996 7:36:00 AM
From: Richard Mazzarella   of 4342
 
Rick, I am starting to believe that we have a sea change for investment in PRLN since the phone conference. The investment promise for PRLN was herbal drugs to cure cancer and AIDS. There has always been a issue of proprietary protection for PRLN's drugs that has hurt the stock price. A great concept and great results without proprietary protection is great for patients, but worthless for shareholders. I can now understand Babish's excitement because PRLN will be able to patent the combinational therapy. Also, they said that they need less of the drugs for effective therapy. IMO. PRLN is a much more valuable company now than it was before the phone conference. Comments?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext